RNA-binding proteins as therapeutic targets in cancer
RNA-binding proteins (RBPs) have emerged as critical regulators of cancer progression, influencing virtually all hallmarks of cancer. Their ability to modulate gene expression patterns that promote or inhibit tumorigenesis has positioned RBPs as promising targets for novel anti-cancer therapies. Thi...
Saved in:
| Main Authors: | Jennifer Jungfleisch, Fátima Gebauer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | RNA Biology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15476286.2025.2470511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer–ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy
by: Bei Xia, et al.
Published: (2025-05-01) -
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential
by: Xing Ren, et al.
Published: (2025-04-01) -
RNA nanostructures for targeted drug delivery and imaging
by: Laura Teodori, et al.
Published: (2024-12-01) -
Oligonucleotide-based PROTACs to Degrade RNA- and DNA-Binding Proteins
by: Céline N. Weller, et al.
Published: (2025-03-01) -
RNA-binding proteins and autophagy in lung cancer: mechanistic insights and therapeutic perspectives
by: Xiao Lei, et al.
Published: (2025-04-01)